Aurora Cannabis Brings Premium Whistler Brand To Australia With High-THC Craft Strains

Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB), the Canadian-based leading global medical cannabis company, announces the launch of Whistler Cannabis Co. in Australia. As one of Canada's original cannabis brands, with a proud history of growing premium, indoor craft cannabis, this unique brand offers Australian patients a true Canadian cannabis experience.

"Whistler is a tried-and-true brand in the Canadian market," said Andre Jerome, Executive Vice President of Global Business Development at Aurora. "We're excited to now extend its legacy, and our Canadian cultivation expertise, to Australian patients. This milestone underscores our commitment to global growth and our patient-first approach."

First developed in 2013, Whistler is cultivated in Aurora's state-of-the-art facility, Aurora Alpine, located in Pemberton Valley, British Columbia. Produced in small batches using top-tier, proprietary genetics, each plant is harvested at its peak ensuring consistent quality. The premium craft medical cannabis flower is hang-dried and hand-trimmed, undergoing a slow, controlled drying process to preserve delicate trichomes – which contain most of the plant's aroma, cannabinoids, and active compounds.

The first two Whistler Cannabis Co. products to launch in Australia are:

• Ginger Breath – 32% THC, Indica, 10g, bred from '91 Royale and Driftwood Diesel genetics, and has a terpene profile of Caryophyllene, Pinene, and Linalool. This cultivar has a complex aroma profile of spicy-ginger, gasoline, chai and citrus.
• Critical Diesel – 28% THC, Sativa, 10g, bred from Critical Sensi Star and Driftwood Diesel lineages, and has a terpene profile of Caryophyllene, Pinene, and Myrcene. This cultivar has a fruity aroma profile of cherry, grape, strawberry, vanilla and gasoline.